Showing 1 - 6 results of 6 for search 'Mónica Bequet Romero', query time: 0.03s Refine Results
  1. 1
    Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived free-VEGF

    Potential mechanisms involved on how systemic IgG antibodies specific to vascular endothelial growth factor (VEGF) and induced by active immunotherapy decrease platelet derived fre... by Javier Sánchez Ramírez, Yanelys Morera Díaz, Mónica Bequet-Romero, Marta Ayala Ávila

    Published 2022-10-01
    Get full text
    Article
  2. 2
    Mutated variant of human vascular endothelial growth factor as a vaccine candidate for cancer immunotherapy

    Mutated variant of human vascular endothelial growth factor as a vaccine candidate for cancer immunotherapy by Mónica Bequet-Romero, Yanelys Morera, Marta Ayala, Boris E Acevedo, Humberto Lamdan, Jorge V Gavilondo

    Get full text
    Article
  3. 3
    Efectos sistémicos del tratamiento intralesional con factor de crecimiento epidérmico (Heberprot-P) en pacientes con úlceras de pie diabético

    Efectos sistémicos del tratamiento intralesional con factor de crecimiento epidérmico (Heberprot-P) en pacientes con úlceras de pie diabético by Ariana García Ojalvo, Jorge Berlanga Acosta, Yssel Mendoza Marí, Maday Fernández Mayola, Mónica Béquet Romero, Calixto Valdés Pérez, William Savigne Gutiérrez, Alain Figueroa Martínez, Ileydis Iglesias Marichal, Eduardo Álvarez Seijas, Amirelia Fabelo Martínez, Gerardo Guillén Nieto

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate

    Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate by Ileanet Ávalos, Thailin Lao, Elsa María Rodríguez, Yasser Zamora, Alianet Rodríguez, Ailyn Ramón, Gilda Lemos, Ania Cabrales, Monica Bequet-Romero, Dionne Casillas, Ivan Andújar, Luis Ariel Espinosa, Luis Javier González, Yanitza Alvarez, Yamila Carpio, Mario Pablo Estrada

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood

    Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood by Dania Vázquez-Blomquist, PhD, Mónica Bequet-Romero, PhD, Yssel Mendoza-Marí, PhD, Gilda Lemos, MSc, Iris Valdés, PhD, Camila Canaán-Haden Ayala, Isabel Gonzáles Moya, Ricardo Martínez Rosales, Giselle Freyre Corrales, Gerardo Guillén-Nieto, PhD

    Published 2022-12-01
    Get full text
    Article
  6. 6
    Péptido inmumodulador CIGB-258 para el tratamiento de pacientes graves y críticos con la COVID-19

    Péptido inmumodulador CIGB-258 para el tratamiento de pacientes graves y críticos con la COVID-19 by Rafael Venegas Rodríguez, Rubén Peña Ruiz, Raúl Santana Sánchez, Mónica Bequet-Romero, Mabel Hernández-Cedeño, Beatriz Santiesteban Licea, Ariana García, Pedro Rafel Aroche de Dios, Daniela Oliva Pérez, Leticia Rosario Cruz, Idelsis Esquivel Moynelo, Maura García Sánchez, Gillian Martínez-Donato, Gerardo Guillén-Nieto, María del Carmen Domínguez Horta

    Published 2020-10-01
    Get full text
    Article

Search Tools: